【行业深度】洞察2025：中国医药流通行业竞争格局及排名情况（附市场集中度、企业排名等）

前瞻产业研究院2025-08-04

行业主要上市公司：国药控股(01099.HK);上海医药(601607.SH);华润医药(03320.HK);九州通(600998.SH);南京医药(600713.SH);华东医药(000963.SZ);英特集团(000411.SZ)等本文核心数据：战略集群;市场排名;波特五力模型;中国医药流通市场竞争梯队目前我国医药流通行业企业可以划分为三个竞争梯队。处于第一梯队的是全国性批发巨头，中国医药、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556402808?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-04 14:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556402808","market":"hk","top_or_hot":-1,"title":"【行业深度】洞察2025：中国医药流通行业竞争格局及排名情况（附市场集中度、企业排名等）","media":"前瞻产业研究院","content":"<div>\n<p>行业主要上市公司：国药控股(01099.HK);上海医药(601607.SH);华润医药(03320.HK);九州通(600998.SH);南京医药(600713.SH);华东医药(000963.SZ);英特集团(000411.SZ)等本文核心数据：战略集群;市场排名;波特五力模型;中国医药流通市场竞争梯队目前我国医药流通行业企业可以划分为三个竞争梯队。处于第一梯队的是全国性批发巨头，中国医药、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414051997320e38&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【行业深度】洞察2025：中国医药流通行业竞争格局及排名情况（附市场集中度、企业排名等）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【行业深度】洞察2025：中国医药流通行业竞争格局及排名情况（附市场集中度、企业排名等）\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-04 14:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414051997320e38&s=b><strong>前瞻产业研究院</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>行业主要上市公司：国药控股(01099.HK);上海医药(601607.SH);华润医药(03320.HK);九州通(600998.SH);南京医药(600713.SH);华东医药(000963.SZ);英特集团(000411.SZ)等本文核心数据：战略集群;市场排名;波特五力模型;中国医药流通市场竞争梯队目前我国医药流通行业企业可以划分为三个竞争梯队。处于第一梯队的是全国性批发巨头，中国医药、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414051997320e38&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHPMY","symbol_name":"上海医药ADR","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414051997320e38&s=b","article_id":"2556402808","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080414051997320e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556402808","pubTimestamp":1754287250,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"中国医药流通行业零售药店排名根据榜单，大参林夺得龙头宝座，排名第一，国大药房位居第二，益丰排名第三;老百姓、一心堂位列第4名和第5名。中国医药流通行业上市公司战略集群分析根据2024年上市公司营收和毛利率进行竞争四象限的划分，目前处于导向者的是华润医药、上海医药、九州通和国药控股。行业内未有收入和毛利率双高的企业，在医药流通行业，要做大规模，成本就会面临较高的情况。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"86618":"京东健康-R","600998":"九州通","601607":"上海医药","603233":"大参林","603883":"老百姓","603939":"益丰药房","SHPMY":"上海医药ADR","02607":"上海医药","01099":"国药控股","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1500":"做空集合股","06618":"京东健康","BK1191":"制药","BK1161":"生物科技","YI":"1药网","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","BK1515":"抗疫概念","BK1570":"华润系","BK1574":"生物医药B类股","09939":"开拓药业-B","03320":"华润医药","BK1197":"保健护理产品经销商"},"translate_title":"[Industry Depth] Insight 2025: Competitive Landscape and Ranking of China's Pharmaceutical Distribution Industry (with Market Concentration, Enterprise Ranking, etc.)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":0.9,"600998":0.9,"601607":0.9,"603233":0.9,"603883":0.9,"603939":0.9,"06618":0.9,"SHPMY":0.9,"YI":0.9,"02607":0.9,"03320":0.9,"01099":1,"09939":0.9},"content_text":"行业主要上市公司：国药控股(01099.HK);上海医药(601607.SH);华润医药(03320.HK);九州通(600998.SH);南京医药(600713.SH);华东医药(000963.SZ);英特集团(000411.SZ)等本文核心数据：战略集群;市场排名;波特五力模型;中国医药流通市场竞争梯队目前我国医药流通行业企业可以划分为三个竞争梯队。处于第一梯队的是全国性批发巨头，中国医药、上海医药、华润医药及九州通，收入在千亿以上水平;处于第二梯队的是广州医药、南京医药、重庆医药等，业务布局以发展核心地区为主，营收在千亿以下，但同时有形成一定规模;其他绝大多数企业则处于第三梯队。中国医药流通行业零售药店排名根据榜单，大参林夺得龙头宝座，排名第一，国大药房位居第二，益丰排名第三;老百姓、一心堂位列第4名和第5名。值得注意的是，今年榜单前5名顺序，与2022-2023年年变化较大。另外，海王星辰、全亿健康、漱玉平民、健之佳、北京同仁堂进入榜单前10;河南张仲景大药房、西安怡康医药、贵州一树、山东立健大药房、安徽国胜(属华人健康)、山东燕喜堂等连锁药店企业跻身榜单前25位。中国医药流通行业电商品牌排名从医药流通电商App排名上看，方舟健客网上药店排名第一，以科技创新开启H2H(Hospital To Home—从医院到家庭)智慧医疗新生态模式。1药网在美股上市，是中国互联网医药健康的领军企业，致力于以科技赋能商业去更好地服务大众(T2B2C)，用数字科技将患者和药品及医疗服务有机连接，打造中国最大的医药健康平台。京东健康依托京东集团的物流基础设施，建立了覆盖全国大部分地区的药品配送网络，从中心城市到偏远乡镇都有渗透。中国医药流通行业上市公司战略集群分析根据2024年上市公司营收和毛利率进行竞争四象限的划分，目前处于导向者的是华润医药、上海医药、九州通和国药控股。这些企业收入超千亿，进入行业较早，凭借经验优势发展较为成熟，业务布局较为全面，营收规模较大。而毛利率实现较好的企业有益丰药房、华东医药、大参林、百洋医药、老百姓、一心堂、北大医药等，这些企业利润留存较好，处于突出者的地位。行业内未有收入和毛利率双高的企业，在医药流通行业，要做大规模，成本就会面临较高的情况。中国医药流通行业竞争状态总结从五力竞争模型角度分析，目前行业竞争激烈，参与者众多，不仅有医药批发企业，还有医药零售企业，目前还有医药品牌运营企业也逐步加入医药流通供应链的市场，药品和药械公司为了降本增效，也开始进行自营，此外电商和互联网企业也加入医药流通行业市场。上游目前主要是供应链和药品企业，这些企业对区域销售和调度议价能力较低，下游主要是医疗机构和患者，这些人对于流通的费用有一定议价能力。目前潜在进入者威胁较大，替代品威胁较小。根据以上分析，对各方面的竞争情况进行量化，1代表最大，0代表最小，目前我国医药流通行业五力竞争总结如下：","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556402808","isCrawlerRequest":true}